Published in J Med Microbiol on February 01, 1987
Surfaceome of Leptospira spp. Infect Immun (2005) 1.90
Global analysis of outer membrane proteins from Leptospira interrogans serovar Lai. Infect Immun (2002) 1.89
Outer membrane proteins of pathogenic spirochetes. FEMS Microbiol Rev (2004) 1.87
LipL21 is a novel surface-exposed lipoprotein of pathogenic Leptospira species. Infect Immun (2003) 1.44
Identification and characterization of the dTDP-rhamnose biosynthesis and transfer genes of the lipopolysaccharide-related rfb locus in Leptospira interrogans serovar Copenhageni. J Bacteriol (1997) 1.02
Antigens recognized by the human immune response to severe leptospirosis in Barbados. Epidemiol Infect (1991) 1.00
Functional analysis of genes in the rfb locus of Leptospira borgpetersenii serovar Hardjo subtype Hardjobovis. Infect Immun (2000) 0.90
Development of a monoclonal antibody-based competitive enzyme-linked immunosorbent assay for the detection of Leptospira borgpetersenii serovar hardjo type hardjobovis antibodies in bovine sera. Can J Vet Res (1997) 0.90
Characterization of an antigenic oligosaccharide from Leptospira interrogans serovar pomona and its role in immunity. Infect Immun (1994) 0.87
Use of recombinant flagellin protein as a tracer antigen in a fluorescence polarization assay for diagnosis of leptospirosis. Clin Diagn Lab Immunol (1999) 0.82
Evolutionary implication of outer membrane lipoprotein-encoding genes ompL1, UpL32 and lipL41 of pathogenic Leptospira species. Genomics Proteomics Bioinformatics (2009) 0.80
The leptospiral outer membrane. Curr Top Microbiol Immunol (2015) 0.78
Comparative analysis of lipopolysaccharides of pathogenic and intermediately pathogenic Leptospira species. BMC Microbiol (2015) 0.77
Production and characterization of monoclonal antibodies specific for Leptospira borgpetersenii serovar hardjo type hardjobovis and Leptospira interrogans serovar hardjo type hardjoprajitno. Can J Vet Res (1999) 0.75
Production and characterization of monoclonal antibodies against Serpulina hyodysenteriae and S. innocens and their use in serotyping. J Clin Microbiol (1995) 0.75
Detection of specific anti-leptospiral immunoglobulins M and G in human serum by solid-phase enzyme-linked immunosorbent assay. J Clin Microbiol (1980) 2.99
H-2 restriction of cell-mediated immunity to an intracellular bacterium: effector T cells are specific for Listeria antigen in association with H-21 region-coded self-markers. J Exp Med (1977) 2.71
Functional organization and nucleotide sequence of virulence Region-2 on the large virulence plasmid in Shigella flexneri 2a. Mol Microbiol (1989) 2.68
The antibodies involved in the human immune response to leptospiral infection. J Med Microbiol (1978) 2.57
Temperature-regulated expression of invasion genes in Shigella flexneri is controlled through the transcriptional activation of the virB gene on the large plasmid. Mol Microbiol (1991) 2.52
Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc Natl Acad Sci U S A (2001) 2.48
Use of a novel approach, termed island probing, identifies the Shigella flexneri she pathogenicity island which encodes a homolog of the immunoglobulin A protease-like family of proteins. Infect Immun (1997) 2.17
Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial. JAMA (2001) 2.06
Genetic organization of Pasteurella multocida cap Loci and development of a multiplex capsular PCR typing system. J Clin Microbiol (2001) 1.93
Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med (1997) 1.92
Morphological and serological analysis of leptospiral structure. Nature (1966) 1.92
Leptospira fainei sp. nov., isolated from pigs in Australia. Int J Syst Bacteriol (1998) 1.77
Ferric dicitrate transport system (Fec) of Shigella flexneri 2a YSH6000 is encoded on a novel pathogenicity island carrying multiple antibiotic resistance genes. Infect Immun (2001) 1.61
Cell-mediated immunity to vesicular stomatitis virus infections in mice. Exp Cell Biol (1978) 1.57
Host immunological mechanisms in the resistance of mice to leptospiral infections. Infect Immun (1977) 1.56
The sigA gene which is borne on the she pathogenicity island of Shigella flexneri 2a encodes an exported cytopathic protease involved in intestinal fluid accumulation. Infect Immun (2000) 1.55
Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir. AIDS (2001) 1.50
Comparative analysis of the LPS biosynthetic loci of the genetic subtypes of serovar Hardjo: Leptospira interrogans subtype Hardjoprajitno and Leptospira borgpetersenii subtype Hardjobovis. FEMS Microbiol Lett (1999) 1.44
Heated sheep or horse serum substitute for rabbit serum in culture media for Leptospira. Appl Microbiol (1968) 1.43
Genetic organization of the she pathogenicity island in Shigella flexneri 2a. Microb Pathog (2001) 1.42
Tracking of blood pressure over an eight year period in Jerusalem school children. J Clin Epidemiol (1988) 1.40
Routine ventilation scans in children with cystic fibrosis: diagnostic usefulness and prognostic value. Eur J Nucl Med (2001) 1.40
Nucleotide sequence of the rhamnose biosynthetic operon of Shigella flexneri 2a and role of lipopolysaccharide in virulence. J Bacteriol (1994) 1.38
Susceptibility of mice treated with cyclophosphamide to lethal infection with Leptospira interrogans Serovar pomona. Infect Immun (1976) 1.38
Genetic analysis of the biosynthesis of non-ribosomal peptide- and polyketide-like antibiotics, iron uptake and biofilm formation by Bacillus subtilis A1/3. Mol Genet Genomics (2004) 1.37
A monoclonal antibody reacting with a determinant on leptospiral lipopolysaccharide protects guinea pigs against leptospirosis. J Med Microbiol (1986) 1.35
Natural antibody in mammalian serum reacting with an antigen in some leptospires. J Bacteriol (1968) 1.32
Quantification of adiposity in small rodents using micro-CT. Methods (2009) 1.28
Interspecies recA protein substitution in Escherichia coli and Proteus mirabilis. Mol Gen Genet (1982) 1.28
Nested deletions of the SRL pathogenicity island of Shigella flexneri 2a. J Bacteriol (2001) 1.27
Prenatal and postnatal diagnosis and carrier detection of Fanconi anemia by a cytogenetic method. Pediatrics (1981) 1.26
Rapid microbiological assay of antibiotic in blood and other body fluids. Lancet (1968) 1.25
Name-based reporting of HIV-positive test results as a deterrent to testing. Am J Public Health (1999) 1.24
The molecular biology of pasteurella multocida. Vet Microbiol (2000) 1.24
Molecular analysis of the aroA gene of Pasteurella multocida and vaccine potential of a constructed aroA mutant. Mol Microbiol (1992) 1.22
Adhesion of leptospires to mouse fibroblasts (L929) and its enhancement by specific antibody. J Med Microbiol (1984) 1.20
Antigens recognised by the human immune response to infection with Leptospira interrogans serovar hardjo. J Med Microbiol (1988) 1.19
Role of capsule in the pathogenesis of fowl cholera caused by Pasteurella multocida serogroup A. Infect Immun (2001) 1.19
Epidemiological studies on head lice infestation in Israel. I. Parasitological examination of children. Int J Dermatol (1990) 1.19
Electron-microscopic evidence for reactions of axial filaments of Leptospira with IgM and IgG antibodies. Bull World Health Organ (1970) 1.17
Chemical, serological and biological properties of a serotype-specific polysaccharide antigen in Leptospira. Aust J Exp Biol Med Sci (1974) 1.16
Molecular analysis of the hsp (groE) operon of Leptospira interrogans serovar copenhageni. Mol Microbiol (1993) 1.16
Genetic differences among the LPS biosynthetic loci of serovars of Leptospira interrogans and Leptospira borgpetersenii. FEMS Immunol Med Microbiol (2001) 1.15
Genetic organisation of the capsule biosynthetic locus of Pasteurella multocida M1404 (B:2). Vet Microbiol (2000) 1.15
Pasteurella multocida: diseases and pathogenesis. Curr Top Microbiol Immunol (2012) 1.13
Genetic organization of the lipopolysaccharide O-antigen biosynthetic locus of Leptospira borgpetersenii serovar Hardjobovis. Microb Pathog (1999) 1.12
Interactions of virulent and avirulent leptospires with primary cultures of renal epithelial cells. J Med Microbiol (1986) 1.12
Experimental immunisation of hamsters with lipopolysaccharide antigens of Leptospira interrogans. J Med Microbiol (1989) 1.11
The capsule biosynthetic locus of Pasteurella multocida A:1. FEMS Microbiol Lett (1998) 1.10
Reaction of monoclonal antibodies with species specific determinants in Leptospira interrogans outer envelope. J Med Microbiol (1988) 1.10
Classification of Leptospira genomospecies 1, 3, 4 and 5 as Leptospira alstonii sp. nov., Leptospira vanthielii sp. nov., Leptospira terpstrae sp. nov. and Leptospira yanagawae sp. nov., respectively. Int J Syst Evol Microbiol (2012) 1.10
The capsule is a virulence determinant in the pathogenesis of Pasteurella multocida M1404 (B:2). Infect Immun (2000) 1.09
Cross-reactivity of the axial filament antigen as a criterion for classification of Leptospira. Aust J Exp Biol Med Sci (1974) 1.09
Community diagnosis of physical growth of infants based on monitoring in a routine preventive service. J Epidemiol Community Health (1979) 1.09
Stimulation of nitric oxide production in macrophages by Babesia bovis. Infect Immun (1998) 1.09
Ultrastructure and chemical composition of lipopolysaccharide extracted from Leptospira interrogans serovar copenhageni. J Gen Microbiol (1986) 1.09
Childhood injuries: a population-based study of emergency room visits in Jerusalem. Paediatr Perinat Epidemiol (1989) 1.09
The enzyme-linked immunosorbent assay (ELISA) as a serological test for detecting antibodies against Leptospira interrogans serovar hardjo in sheep. Aust Vet J (1981) 1.09
Variants of human tissue-type plasminogen activator that lack specific structural domains of the heavy chain. EMBO J (1988) 1.08
Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem. Ann Intern Med (1999) 1.08
Serological and protective-antibody responses of rabbits to leptospiral antigens. J Med Microbiol (1978) 1.08
Lipopolysaccharide biosynthesis in Leptospira. J Mol Microbiol Biotechnol (2000) 1.07
Fanconi anemia: prenatal diagnosis in 30 fetuses at risk. Pediatrics (1985) 1.07
Conversion of a Golgi apparatus sialyltransferase to a secretory protein by replacement of the NH2-terminal signal anchor with a signal peptide. J Biol Chem (1989) 1.06
A pomona serogroup-specific, agglutinating antigen in Leptospira, identified by monoclonal antibodies. Pathology (1983) 1.05
High-resolution computed tomography of drug-induced lung disease. Clin Radiol (1992) 1.05
High-resolution computed tomography of the chest: current indications. J Thorac Imaging (1993) 1.04
Fatal congenital human leptospirosis. Zentralbl Bakteriol Mikrobiol Hyg A (1984) 1.04
Curli loci of Shigella spp. Infect Immun (2000) 1.04
Molecular analysis of the dnaK locus of Leptospira interrogans serovar Copenhageni. Gene (1998) 1.04
Trypanosoma brucei mitochondrial ribosomal RNA synthesis, processing and developmentally regulated expression. Mol Biochem Parasitol (1992) 1.04
Insertional and deletional RNA editing in trypanosome mitochondria. Nucleic Acids Symp Ser (1997) 1.03
Body size of Israeli newborn infants in relation to regional origin of their mothers. Hum Biol (1977) 1.03
Vaccination of mice with lipopolysaccharide (LPS) and LPS-derived immuno-conjugates from Leptospira interrogans. J Med Microbiol (1990) 1.03
Technological advances in the molecular biology of Leptospira. J Mol Microbiol Biotechnol (2000) 1.03
Cloning, sequencing, expression, and protective capacity of the oma87 gene encoding the Pasteurella multocida 87-kilodalton outer membrane antigen. Infect Immun (1996) 1.03
Identification and characterization of the dTDP-rhamnose biosynthesis and transfer genes of the lipopolysaccharide-related rfb locus in Leptospira interrogans serovar Copenhageni. J Bacteriol (1997) 1.02
Cross protective immunity conferred by a marker-free aroA mutant of Pasteurella multocida. Vaccine (1997) 1.01
Detection of leptospires in biological fluids using DNA hybridisation. Vet Microbiol (1987) 1.01
Does anemia in infancy affect achievement on developmental and intelligence tests? Hum Biol (1983) 1.01